Related references
Note: Only part of the references are listed.Perfluoroalkyl substances and changes in body weight and resting metabolic rate in response to weight-loss diets: A prospective study
Gang Liu et al.
PLOS MEDICINE (2018)
C57BL/6 Substrains Exhibit Different Responses to Acute Carbon Tetrachloride Exposure: Implications for Work Involving Transgenic Mice
Jennifer M. McCracken et al.
GENE EXPRESSION (2017)
PPARα-independent transcriptional targets of perfluoroalkyl acids revealed by transcript profiling
Mitchell B. Rosen et al.
TOXICOLOGY (2017)
The SCAP/SREBP Pathway: A Mediator of Hepatic Steatosis
Young-Ah Moon
ENDOCRINOLOGY AND METABOLISM (2017)
Longitudinal Associations of Exposure to Perfluoroalkylated Substances in Childhood and Adolescence and Indicators of Adiposity and Glucose Metabolism 6 and 12 Years Later: The European Youth Heart Study
Sidsel L. Domazet et al.
DIABETES CARE (2016)
Hepatocyte-Specific Disruption of CD36 Attenuates Fatty Liver and Improves Insulin Sensitivity in HFD-Fed Mice
Camella G. Wilson et al.
ENDOCRINOLOGY (2016)
Global Epidemiology of Nonalcoholic Fatty Liver Disease-Meta-Analytic Assessment of Prevalence, Incidence, and Outcomes
Zobair M. Younossi et al.
HEPATOLOGY (2016)
The role of hepatocyte nuclear factor 4-alpha in perfluorooctanoic acid- and perfluorooctanesulfonic acid-induced hepatocellular dysfunction
Kevin M. Beggs et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2016)
Hepatocellular carcinoma
Josep M. Llovet et al.
NATURE REVIEWS DISEASE PRIMERS (2016)
Berberine Ameliorates Hepatic Steatosis and Suppresses Liver and Adipose Tissue Inflammation in Mice with Diet-induced Obesity
Ting Guo et al.
SCIENTIFIC REPORTS (2016)
Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013
Mohsen Naghavi et al.
LANCET (2015)
Identification of Environmental Chemicals Associated with the Development of Toxicant-associated Fatty Liver Disease in Rodents
Laila Al-Eryani et al.
TOXICOLOGIC PATHOLOGY (2015)
Hepatocyte-specific deletion of hepatocyte nuclear factor-4 alpha in adult mice results in increased hepatocyte proliferation
Chad Walesky et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2013)
Liver-Specific Cholesteryl Ester Hydrolase Deficiency Attenuates Sterol Elimination in the Feces and Increases Atherosclerosis in Ldlr-/- Mice
Jinghua Bie et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2013)
Glucose and lipid homeostasis in adult rat is impaired by early-life exposure to perfluorooctane sulfonate
Ziquan Lv et al.
ENVIRONMENTAL TOXICOLOGY (2013)
PFOS-induced hepatic steatosis, the mechanistic actions on β-oxidation and lipid transport
H. T. Wan et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2012)
The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
Naga Chalasani et al.
HEPATOLOGY (2012)
Chronic dietary toxicity and carcinogenicity study with potassium perfluorooctanesulfonate in Sprague Dawley rats
John L. Butenhoff et al.
TOXICOLOGY (2012)
Hepatocellular hypertrophy and cell proliferation in Sprague-Dawley rats from dietary exposure to potassium perfluorooctanesulfonate results from increased expression of xenosensor nuclear receptors PPARα and CAR/PXR
Clifford R. Elcombe et al.
TOXICOLOGY (2012)
Trends in Exposure to Polyfluoroalkyl Chemicals in the US Population: 1999-2008
Kayoko Kato et al.
ENVIRONMENTAL SCIENCE & TECHNOLOGY (2011)
Role for PPARγ in obesity-induced hepatic steatosis as determined by hepatocyte- and macrophage-specific conditional knockouts
Eva Moran-Salvador et al.
FASEB JOURNAL (2011)
Abrogation of growth hormone secretion rescues fatty liver in mice with hepatocyte-specific deletion of JAK2
Brandon C. Sos et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Increased Activation of the Wnt/β-Catenin Pathway in Spontaneous Hepatocellular Carcinoma Observed in Farnesoid X Receptor Knockout Mice
Andy Wolfe et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2011)
Perfluoroalkyl Sulfonates Cause Alkyl Chain Length-Dependent Hepatic Steatosis and Hypolipidemia Mainly by Impairing Lipoprotein Production in APOE*3-Leiden CETP Mice
Silvia Bijland et al.
TOXICOLOGICAL SCIENCES (2011)
Multiplicity of nuclear receptor activation by PFOA and PFOS in primary human and rodent hepatocytes
J. A. Bjork et al.
TOXICOLOGY (2011)
Perfluoroalkyl and polyfluoroalkyl substances in the environment: Terminology, classification, and origins
Robert C Buck et al.
Integrated Environmental Assessment and Management (2011)
Loss of TGH/Ces3 in Mice Decreases Blood Lipids, Improves Glucose Tolerance, and Increases Energy Expenditure
Enhui Wei et al.
CELL METABOLISM (2010)
Dietary exposure to perfluorooctanoate or perfluorooctane sulfonate induces hypertrophy in centrilobular hepatocytes and alters the hepatic immune status in mice
Mousumi Rahman Qazi et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2010)
Tissue distribution of 35S-labelled perfluorooctane sulfonate (PFOS) in C57Bl/6 mice following late gestational exposure
D. Borg et al.
REPRODUCTIVE TOXICOLOGY (2010)
28-Day dietary exposure of mice to a low total dose (7 mg/kg) of perfluorooctanesulfonate (PFOS) alters neither the cellular compositions of the thymus and spleen nor humoral immune responses: Does the route of administration play a pivotal role in PFOS-induced immunotoxicity?
Mousumi Rahman Qazi et al.
TOXICOLOGY (2010)
Gene Expression Profiling in Wild-Type and PPAR alpha-Null Mice Exposed to Perfluorooctane Sulfonate Reveals PPAR alpha-Independent Effects
Mitchell B. Rosen et al.
PPAR RESEARCH (2010)
Beta-Catenin Activation Promotes Liver Regeneration after Acetaminophen-Induced Injury
Udayan Apte et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Developmental toxicity of perfluorooctane sulfonate (PFOS) is not dependent on expression of peroxisome proliferator activated receptor-alpha (PPARα) in the mouse
Barbara D. Abbott et al.
REPRODUCTIVE TOXICOLOGY (2009)
Evidence for the involvement of xenobiotic-responsive nuclear receptors in transcriptional effects upon perfluoroalkyl acid exposure in diverse species
Hongzu Ren et al.
REPRODUCTIVE TOXICOLOGY (2009)
The atrophy and changes in the cellular compositions of the thymus and spleen observed in mice subjected to short-term exposure to perfluorooctanesulfonate are high-dose phenomena mediated in part by peroxisome proliferator-activated receptor-alpha (PPARα)
Mousumi Rahman Qazi et al.
TOXICOLOGY (2009)
Hepatic fatty acid transporter Cd36 is a common target of LXR, PXR, and PPARγ in promoting steatosis
Jie Zhou et al.
GASTROENTEROLOGY (2008)
Comparative Hepatic Effects of Perfluorooctanoic Acid and WY 14,643 in PPAR-alpha Knockout and Wild-type Mice
Douglas C. Wolf et al.
TOXICOLOGIC PATHOLOGY (2008)
Activation of mouse and human peroxisome proliferator-activated receptor alpha by perfluoroalkyl acids of different functional groups and chain lengths
Cynthia J. Wolf et al.
TOXICOLOGICAL SCIENCES (2008)
Polyfluoroalkyl chemicals in the US population: Data from the National Health and Nutrition Examination Survey (NHANES) 2003-2004 and comparisons with NHANES 1999-2000
Antonia M. Calafat et al.
ENVIRONMENTAL HEALTH PERSPECTIVES (2007)
Half-life of serum elimination of perfluorooctanesulfonate, perfluorohexanesulfonate, and perfluorooctanoate in retired fluorochemical production workers
Geary W. Olsen et al.
ENVIRONMENTAL HEALTH PERSPECTIVES (2007)
trans-activation of PPARα and induction of PPARα target genes by perfluorooctane-based chemicals
JM Shipley et al.
TOXICOLOGICAL SCIENCES (2004)
Triacylglycerol hydrolase: role in intracellular lipid metabolism
VW Dolinsky et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2004)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
Share Paper
